CSIMarket


Innovation Pharmaceuticals Inc   (CTIX)
Other Ticker:  
 

Innovation Pharmaceuticals Inc

CTIX's Fundamental analysis








Innovation Pharmaceuticals Inc 's sales fell in I. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.75 %

Innovation Pharmaceuticals Inc net loss decreased from $-1 millions, to $-1 millions in I. Quarter 2023,

More on CTIX's Growth


Innovation Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.76.


More on CTIX's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Innovation Pharmaceuticals Inc
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.76.